Composition of matter patent application
Ermium Therapeutics consolidates its patent portfolio by filing a composition of matter patent application of new anti-inflammatory compounds.
Ermium Therapeutics consolidates its patent portfolio by filing a composition of matter patent application of new anti-inflammatory compounds.
Ermium has been granted 1 200 000 € within the frame of the “Aide au Développement Deeptech” program (Support to Deeptech Development) from Bpifrance, the French agency for innovation, to move forward its therapeutic approach for auto-immune diseases including systemic lupus erythematosus, Sjögren’s syndrome and other type I interferon driven diseases
Ermium Therapeutics © 2024 All Rights Reserved
Design by Cédric Adam